INNLIFES interview - VRG Therapeutics is the most innovative proposal of MIT4LS 2023
INNLIFES, an Italian online life science journal has published an interview with Tamás Kitka, PhD, our Director of Innovation and Portfolio. It covers VRG-K1, lead molecule of Kv1.3 project and our two proprietary platforms, ISEP and CREATe. Note: The original language of this interview is Italian and was translated to English using Google Translate.
Introduction
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
November 6, 2023
SHARE THIS ON
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
November 6, 2023
SHARE THIS ON
Introduction
Latest
News
The latest industry news, interviews, technologies, and resources.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.